Indian government has set up a panel to fix prices of patented drugs in the country.
'I was in awe of how committed Kareena was, even at this stage of her career.' 'She is so motivated, giving it her all. 'It was very inspiring and motivating, not just for me, but for everyone else to pull up their socks and give it their all.'
Sun Pharmaceutical Industries Ltd Chairman Dilip Shanghvi said he expects Ranbaxy Laboratories Ltd to become profitable in the short term.
What sold the most this year? Beauty, toys and baby care, sports and fitness, television and large appliances, followed by fashion, says T E Narasimhan.
A brand mascot personifies the brand very effectively. They have the capacity to create a better brand recall and strong positioning for a brand. Take this quiz to find out if these mascot have managed to leave a lasting impression.
Ranbaxy Laboratories Ltd, which has profited handsomely by selling generic drugs in the United States, said on Tuesday it would increase its R&D spending by about 60 per cent over the next five years.
Global companies, e-commerce platforms and software product firms all want skilled digital workers.
The challenge of merging Ranbaxy into the company has not been factored in.
Free Basics offers a limited version of the Internet on mobile phones.
The order, a "negative" overall, will be a short term positive for corporate focused state-run and private lenders because of the possibility of delaying incremental stressed asset recognition.
Netmeds is looking at using new technologies such as deep learning and data analytics to improve forecasting in terms of the demand of the products for pharma companies, reports Peerzada Abrar.
The founders of Gland Pharma, led by Ravi Penmetsa, and KKR, together own 96 per cent of the company.
Basic Customs Duty is being reduced to 2.5 per cent for the equipments required for setting up or substantial expansion of iron ore pellet plants & iron ore beneficiation plants.
DRL launched four new products in North America during the previous quarter.
The deal had separately come under scanner of the market regulator Sebi for alleged insider trading violations and the present 'no-objection' from the exchanges.
India has a huge trade surplus with US - over $20 billion a year in the past five years.
Mylan had sued the United States Food and Drugs Administration for providing the exclusive right to Ranbaxy, alleging the permission was given on the basis of 'falsified data'.
Rs 1,965-cr deal helps it rake in 3.5 times its investment within four years.
'Despite expanded testing the incidence remains low.' 'Therefore, the focus should be on specific districts where we need to improve the testing.' 'We should have a district-centric strategy.'
'It is clear that economic policy and reform under this administration will always be afterthoughts, something to be carried out only when no other political concern intervenes -- when, in other words, the government feels safe and comfortable enough to take a moderate risk,' argues Mihir S Sharma.
India could offer a train track to China to run a bullet train besides easy terms to set up industrial parks.
US said access to affordable health care entails a large number of factors from rates, logistics to insurance reforms.
By the time the film winds down in extremely simplistic fashion, we just don't care anymore.
The government on Monday said that multinational companies (MNCs) are campaigning against domestic pharmaceuticals industry as their interests were getting impacted due to increasing global presence of Indian firms in the generic segment.
Indian pharmaceutical companies, which always wanted a big share in the global copycat drug market, are betting high on the oral contraceptive (OC) market in America.
Dr Reddy's Laboratories today said it will form a joint venture with Fujifilm Corporation to develop, manufacture and market generic drugs in Japan.
'The focus for value creation will be on all business segments.'
The Internet Corporation of Assigned Names and Numbers' (ICANN) decision to expand gTLD (generic top-level domain) names on the internet to include almost any name (even .anything), is foxing both users and registers. It has also raised fears of online trademark violations and cybersquatting.
European countries are trying to woo back the Indian customers they had lost following seizure of drug consignments by Customs authorities of several European Union members.
Trade analyst Vinod Mirani gives us the box office verdict for the week.
Changing your body type may seem to be difficult, but you can still manage to get it in great shape. You can be the architect of your own body with these eight simple steps!
Large urban co-operative banks may come to be solely under the provisions of the Banking Regulation Act, even as the smaller among them are to remain within the exclusive fold of the Registrar of Co-operative Societies. The upcoming changes will bring the curtains down on the vexed issue of dual control of UCBs, which has been in vogue for 54 years. The new framework will affect 1,551 UCBs in the country, which had a total business of Rs 7.36 trillion.
Respiratory product paves way for launch in larger markets and greater earnings visibility.
The pact would entail the Indian company receiving up to $38 million (over Rs 165 crore).
According to political pundits, the Democrats have a good chance of winning the House, while the Republicans are likely to retain the Senate.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances